This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Japan-Lamb Inc., Sekisui Medical Co., Ltd., Other. Active years: 2015-2021.
Company Filing History:

Years Active: 2015-2021
Title: Shigeo Sudo: Innovator in Bovine Serum Composition and Antibody Assay Reagents.
Introduction
Shigeo Sudo is a notable inventor based in Fukuyama, Japan. He has made significant contributions to the fields of cell culture and immunology through his innovative patents. With a total of 2 patents, Sudo's work focuses on enhancing the efficiency and effectiveness of biological assays and cell proliferation methods.
Latest Patents
One of Sudo's latest patents is a bovine serum composition and method for culturing cells using said bovine serum composition as an additive. This method provides an economical solution for producing a bovine serum composition rich in factors that promote cell proliferation. The process involves anticoagulation treatment of bovine whole blood, obtaining a buffy coat, and activating interactions between leukocytes and platelets to release humoral factors.
Another significant patent is a reagent for assaying anti-treponema pallidum antibody. This reagent contains a polypeptide antigen that offers high assay sensitivity and specificity. The assay method utilizes a recombinant polypeptide containing specific domains of the 47 kDa antigen, which enhances the accuracy of antibody detection.
Career Highlights
Throughout his career, Shigeo Sudo has worked with prominent companies such as Sekisui Medical Co., Ltd. and Japan-Lamb Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the medical and biological fields.
Collaborations
Sudo has collaborated with notable colleagues, including Michiko Kawamoto and Kenichi Yamahara. These partnerships have likely facilitated the exchange of ideas and advancements in their respective areas of research.
Conclusion
Shigeo Sudo's contributions to the fields of cell culture and immunology through his patents demonstrate his commitment to innovation. His work continues to impact the scientific community positively, paving the way for advancements in medical research and applications.